Back to WESTFIELD CAPITAL MANAGEMENT CO LP WESTFIELD CAPITAL MANAGEMENT CO LP

VRTXVRTX
Showing 6 of 17 quarters

Position history for WESTFIELD CAPITAL MANAGEMENT CO LPWESTFIELD CAPITAL MANAGEMENT CO LP's holdings in VERTEX PHARMACEUTICALS INC

Yes. Westfield Capital Management holds 2,189 shares of VRTX (Vertex Pharmaceuticals), worth $1.1M, as of its Q2 2026 13F filing. It increased the position by 1,325 shares (+153.4%) from Q1 2026. Westfield Capital Management has held VRTX since Q4 2025, across 3 quarterly 13F filings.

Current Value

$1.1M

Current Shares

2,189

Total Value Change

+$495,760

Total Shares Change

+917

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2,189
+153.4%
$1.1M0.0%$496.73
41
2026-Q1
Decreased
864
-23.7%
$385,8110.0%$446.54
0
2025-Q4
New
1,132
-
$513,2040.0%$453.36
33
2025-Q1
Exited
0
-100.0%
$00.0%$484.82
0
2024-Q4
Increased
1,742
+37.0%
$701,5030.0%$402.70
32
2024-Q3
Increased
1,272
+133.8%
$591,5820.0%$465.08
39

Other major holders of VRTX: Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used